CTRI/2021/07/034572
Not yet recruiting
Phase 2
Open Labelled Clinical study to Evaluate the Effect of Draksha (Vitis Vinifera Lin) Panak in Dyslipidaemia.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: E784- Other hyperlipidemia
- Sponsor
- Sane Guruji Arogya Kendra
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patient of age group 20 to 50 years,irrespective of their gender, religion.
- •2\.Patients with abnormal Sr. lipid levels are singly, or in the cluster of two or all three.
- •3\.Irrespective of taking lipid lowering drug therapy.
- •4\.Irrespective of family hidtory of Atherosclerotic Cardiovascular Disease (ASCVD), Dyslipidaemia.
- •5\.Patient irrespective of known case of HTN.
Exclusion Criteria
- •1\.Patient with Mrudu koshta.
- •2\.Patient known case of Diabetes Mellitus.
- •3\.pregnant Woman.
- •4\.Patient with known case of Atherosclerotic Cardiovascular Disease/ ischemic heart disease.
- •5\.Patient with operated for heart blockages like PTCA or Bypass surgery.
- •6\. Patient with known congenital heart disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study to Determine the Effect of Trucrose in Patients with Type II Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2020/07/026346Trulit Herbals
Not yet recruiting
Phase 3
A CLINICAL STUDY TO KNOW THE EFFECT OF AN AYURVEDIC FORMULATION (GUDA-HARITAKI WITH GUDUCHI KASHAYAM) FOR THE TREATMENT OF VATA RAKTA, GOUTY ARTHRITIS.Health Condition 1: M100- Idiopathic goutCTRI/2022/09/045834Jammu Institute of Ayurveda and Research Jammu
Not yet recruiting
Phase 2
Improvement of Intelligence by Ayurveda medicineCTRI/2020/09/027633Rajiv Gandhi University of Health Sciences Karnataka
Not yet recruiting
Phase 2
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)CTRI/2017/12/011004The Himalaya Drug Company
Completed
Phase 4
A clinical study to evaluate the efficacy and safety of URAL tabletCTRI/2023/04/051931Vasu Research Centre